Prof. Horst Sievert

Horst Sievert

Interventional cardiologist / Cardiologist
CVC - Frankfurt, Germany

EDUCATION

1979 Medical Degree

1980 Doctorate MD, Johann Wolfgang Goethe University Frankfurt, Germany

1988 Board certified in Cardiology, Frankfurt, Germany

1990 State Doctorate, PhD, Johann Wolfgang Goethe University Frankfurt, Germany

1990 - 1993 Chief of Cardiology at Heart and Vascular Center Rotenburg an der Fulda, Germany

1993 - 2003 Senior Consultant at Cardiovascular Center Bethanien (CCB), Bethanien Hospital Frankfurt, Germany

Since 2003 Director CVC Frankfurt, St. Katharinen Hospital Frankfurt, Germany

ACTIVE AREAS OF RESEARCH

Director and Founder of CVC Frankfurt in 2003

Specialist in Internal Medicine, Cardiology, Angiology, and Intensive Care

Medical degree from Johannes Gutenberg University Mainz and Johann Wolfgang Goethe University Frankfurt, Germany

Declaration of interest

FunctionCompany
Grants/research supportAbbott Vascular
Grants/research supportAccess Closure
Grants/research supportAGA
Grants/research supportArstasis
Grants/research supportAtritech
Grants/research supportAtrium
Grants/research supportAvinger
Grants/research supportBard
Grants/research supportBoston Scientific
Grants/research supportBridgepoint
Grants/research supportCardiac Dimensions
Grants/research supportCardiokinetix
Grants/research supportCardioMEMS
Grants/research supportCoherex
Grants/research supportContego
Grants/research supportCook Medical
Grants/research supportCordis Cardiac & Vascular Institute

Latest contributions

Academic Research Consortium initiative on left atrial appendage closure – standardising definitions and endpoints to move forward

21 May 2025

Philippe Garot describes the EuroPCR 2025 session on left atrial appendage closure (LAAC), which offers a preview of the upcoming new consensus document developed by the Academic Research Consortium.

Dr Philippe Garot

Author

Philippe Garot

Academic Research Consortium on LAA closure

21 May 2025 – From EuroPCR 2025

Gain comprehensive understanding of the Academic Research Consortium's achievements in left atrial appendage (LAA) closure. Learn how standardized endpoints are streamlined for randomized controlled trials and how collaborative efforts homogenize definitions to advance clinical research.

Academic Research Consortium on LAA closure

Embolic protection, TAVI, heart failure and artificial intelligence: what's new in 2023

19 May 2023 – From EuroPCR 2023

This session covers various topics related to transcatheter aortic valve replacement, including the Protect Head-to-Head study on full-body embolic protection during TAVR, the FLOWer device for complete embolic protection, the use of a pulsing aspiration pump for percutaneous thrombectomy, and many more innovation updates from 2023.

Embolic protection, TAVI, heart failure and artificial intelligence: what is new in 2023

EuroPCR 2021 Hotlines / Late-Breaking Trials: PLA-pCi-EBO-pilot, CALM, ISCHEMIA, and more!

26 May 2021 – From EuroPCR 2021

Find out more about various studies & registries in stable CAD:

  • Effects of visualization of PCI results on symptoms in chronic coronary syndrome
  • Effect of Atorvastatin Therapy on Serial Changes of Coronary Flow And Plaque
  • Initial results of a feasibility study of endovascular baroreflex amplification in heart failure patients
  • Impact...
EuroPCR 2021 Hotlines / Late-Breaking Trials: PLA-pCi-EBO-pilot, CALM, ISCHEMIA, and more!

Interventional treatment for heart failure

18 May 2021 – From EuroPCR 2021

Watch this session if you want to learn about interventional techniques for monitoring and treatment of patients with heart failure and to review options for haemodynamic support in patients with acute heart failure.

This session was originally presented during EuroPCR 2021.

Interventional treatment for heart failure

Which patients benefit from PFO closure after stroke?

24 Dec 2019 – From EuroPCR 2019

Consult this session on PFO closure after stroke and learn more about how to diagnose a cryptogenic stroke, work up a patient suspected of having one, and how to identify among them the patients who may benefit from PFO closure.

Which patients benefit from PFO closure after stroke?

New innovative solutions for serious needs: check it out!

28 Aug 2019 – From EuroPCR 2019

Consult this session to discover new innovative solutions for serious needs, such as the Ultraseal device, the V-LAP system, and more!

New innovative solutions for serious needs

Transseptal puncture: Percutaneous left atrial appendage closure

23 May 2019 – From EuroPCR 2019

Consult this session to learn more about how to perform a transseptal puncture in the setting of LAA closure, with a case from Rigshospitalet, Denmark, transmitted live during EuroPCR 2019.

Transcatheter left atrial decompression for chronic heart failure: evidence, indications and device options

23 May 2019 – From EuroPCR 2019

Consult this session to learn more about the role of left atrial decompression in the multidisciplinary management of chronic heart failure, the device selection, their specifics and how to use them, and more!

Transcatheter left atrial decompression for chronic heart failure: evidence, indications and device options

Devices in chronic heart failure: an update for the interventionalist

21 May 2019 – From EuroPCR 2019

Consult this session on device-based monitoring, neuromodulation and left ventricular aneurysmectomy, in order to better understand the contribution of devices to the management of chronic heart failure and the concepts of optimal patient and device selection.

Devices in chronic heart failure: an update for the interventionalist